Market Movers: Morgan Stanley (NYSE:MS), Sumitomo Mitsui Financial Group (NYSE:SMFG), Loews Corporation (NYSE:L), Aldeyra Therapeutics (NASDAQ:ALDX), Tucows Inc. (NASDAQ:TCX)

On Monday shares of Morgan Stanley (NYSE:MS) closed at $38.33. Company’s sales growth for last 5 years was 4.80% and EPS growth for next 5 years is recorded as 15.57%. Morgan Stanley (NYSE:MS) has promoted John Esposito to global co-head of its financial institutions group, a role formerly held by its new chief financial officer Johnathan Pruzan and former CFO, Ruth Porat.

Sumitomo Mitsui Financial Group, Inc. (NYSE:SMFG) in last trading activity increased 2.19% to close at $8.85. Company weekly performance is -1.56% while its quarterly performance stands at 17.22%. Sumitomo Mitsui Financial Group, Inc. (NYSE:SMFG) is -2.85% away from its 52 week high. Sumitomo Mitsui Financial Group, Inc. (NYSE:SMFG) and the Development Bank of Japan are set to take a combined 33.4 percent stake in bankrupt budget carrier Skymark Airlines Inc , giving them veto power over major decisions, sources familiar with the plan said.

On last trading day Loews Corporation (NYSE:L) increased 1.01% to close at $41.05. Its volatility for the week is 1.08% while volatility for the month is 1.27%. L’s sales growth for past 5 years was -1.40% and its EPS growth for past 5 years was 13.90%. Loews Corporation (NYSE:L) monthly performance is -1.89%. On May 12, Loews Corporation (NYSE:L) announced the declaration of the Company’s quarterly dividend of $0.0625 per share of Common Stock, payable June 12, 2015 to shareholders of record on June 1, 2015.

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) has 14.65% insider ownership while its institutional ownership stands at 49.70%. In last trading activity company’s stock closed at $7.29. On May 13, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced its financial results for the first quarter ended March 31, 2015. For the first quarter of 2015, Aldeyra reported a net loss attributable to common stockholders of approximately $2.1 million compared to a net loss of approximately $13,000 for the first quarter of 2014. Basic and diluted net loss per share was $0.32 for the three months ended March 31, 2015 compared to basic net loss per share of $0.04 and diluted net loss per share of $4.04 for the same period in 2014.

On last trading day Tucows Inc. (NASDAQ:TCX) increased 11.53% to close at $22.25. Its volatility for the week is 3.47% while volatility for the month is 2.72%. TCX’s sales growth for past 5 years was 12.80% and its EPS growth for past 5 years was -5.10%. Tucows Inc. (NASDAQ:TCX) monthly performance is 22.66%. Zacks upgraded shares of Tucows (NASDAQ:TCX) from a hold rating to a strong-buy rating in a report released on Monday. Zacks currently has $22.00 price objective on the stock.

News Buzz: Aldeyra Therapeutics (NASDAQ:ALDX), FibroGen (NASDAQ:FGEN), Apple Inc. (NASDAQ:AAPL), UTi Worldwide Inc. (NASDAQ:UTIW), RPX Corporation (NASDAQ:RPXC)

On Monday shares of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) closed at $10.12. On March 19, it was reported that, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that it has started patient enrolment in a phase II study on its investigational candidate NS2 for the treatment of Sjögren-Larsson syndrome. Apart from Sjögren-Larsson syndrome, the candidate is being developed for noninfectious anterior uveitis.

FibroGen, Inc. (NASDAQ:FGEN) in last trading activity advanced 5.83% to close at $31.59. Company weekly performance is 4.88% while its quarterly performance stands at 15.71%. FibroGen, Inc. (NASDAQ:FGEN) is -22.17% away from its 52 week high. FibroGen, Inc. (Nasdaq:FGEN) provided a corporate update and reported financial results for the year-ended December 31, 2014; Total operating expenses were $187.7 million, which includes $23.3 million of non-cash items.

On Monday shares of Apple Inc. (NASDAQ:AAPL) closed at $126.37. Company’s sales growth for last 5 years was 33.60% and EPS growth for next 5 years is recorded as 13.32%. Apple Inc. (NASDAQ:AAPL) is planning to unveil a new 4-inch Touch ID iPhone 6C at the end of the year, says reports. We’re receiving an initial look at the predicted smartphone, which features a somewhat new tweaked build and some additional tricks.

UTi Worldwide Inc. (NASDAQ:UTIW) has 0.20% insider ownership while its institutional ownership stands at 91.20%. In last trading activity company’s stock closed at $12.54. UTi Worldwide Inc. (NASDAQ:UTIW) announced that its fiscal 2015 fourth quarter conference call will be held on Tuesday, March 31, 2015 at 2:00 p.m. PDT (5:00 p.m. EDT) to review its financial results and answer questions.

On last trading day RPX Corporation (NASDAQ:RPXC) advanced 1.97% to close at $14.50. Its volatility for the week is 2.21% while volatility for the month is 2.27%. RPXC’s sales growth for past 5 years was 51.20% and its EPS growth for past 5 years was 6.77%. RPX Corporation (NASDAQ:RPXC) monthly performance is -0.55%.RPX Corp (NASDAQ:RPXC) was upgraded by analysts at TheStreet from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday.

Stocks to Watch: JPMorgan Chase & Co. (NYSE:JPM), TRACON Pharmaceuticals (NASDAQ:TCON), Aldeyra Therapeutics (NASDAQ:ALDX), NCI Building Systems (NYSE:NCS), The Walt Disney (NYSE:DIS)

On Thursday shares of JPMorgan Chase & Co. (NYSE:JPM) closed at $61.20. Company’s sales growth for last 5 years was -4.90% and EPS growth for next 5 years is recorded as 8.07%. A U.S. federal judge tossed out a lawsuit brought by non-profit group Better Markets that sought to block a $13 billion settlement JPMorgan Chase & Co (NYSE:JPM) reached with the U.S. Justice Department over shoddy mortgage loans sold to investors before the financial crisis. Judge Beryl A. Howell accepted a motion by the Justice Department filed last May to dismiss the lawsuit, which argued that the group founded in 2010 to advocate for tough Wall Street reforms lacked standing to sue.

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) in last trading activity fell -5.80% to close at $15.60. Company weekly performance is 9.47%. TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) is -25.71% away from its 52 week high. On March 10, TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) announced its financial results for the year ended December 31, 2014. For the year ended December 31, 2014, TRACON reported a net loss of $6.8 million compared to a net loss of $7.7 million for 2013.

On last trading day Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) fell -5.53% to close at $10.60. Its volatility for the week is 7.13% while volatility for the month is 7.06%. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) monthly performance is -4.07%. On March 17, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that it has opened enrollment for its Phase II clinical trial of NS2 for patients with Sjögren-Larsson Syndrome. In addition, Alderya announced that the U.S. Food and Drug Administration (FDA) has accepted its submission of an amended protocol for its Phase II clinical trial of NS2 in patients with noninfectious anterior uveitis.

NCI Building Systems Inc. (NYSE:NCS) has 1.80% insider ownership while its institutional ownership stands at 95.20%. In last trading activity company’s stock closed at $17.10. NCI Building Systems, Inc. (NYSE:NCS) announced that Norman Chambers, Chairman, President and Chief Executive Officer, will participate in one-on-one meetings at the BB&T 9thAnnual Commercial & Industrial Investor Conference March 26, 2015 in Coral Gables, Florida.

On last trading day The Walt Disney Company (NYSE:DIS) fell -0.56% to close at $107.37. Its volatility for the week is 1.61% while volatility for the month is 1.40%. DIS’s sales growth for past 5 years was 6.20% and its EPS growth for past 5 years was 19.30%. The Walt Disney Company (NYSE:DIS) monthly performance is 3.38%. Latinum Network, America’s premier member-based multicultural advisory firm, is hosting its biannual Executive Roundtable series on March 26, 2015 at the Walt Disney Studios in Burbank, CA. Co-hosted by The Walt Disney Company (NYSE:DIS), this in-person meeting brings together about 50 executives from some of America’s top corporations in order to discuss strategies and best practices in multicultural marketing. Among the Spring Executive Roundtable’s confirmed attendees are representatives from the National Football League, Facebook, Coca-Cola, Discovery US Hispanic Networks, Nestlé USA, and more.

Don’t Miss These Stocks: Second Sight Medical Products (NASDAQ:EYES), Advanced Micro Devices (NASDAQ:AMD), The Timken (NYSE:TKR), China Yuchai (NYSE:CYD), Aldeyra Therapeutics (NASDAQ:ALDX)

Second Sight Medical Products, Inc. (NASDAQ:EYES) will release its 2014 fourth quarter and year-end financial results on Wednesday, March 11, 2015, after the close of the U.S. financial markets. On Wednesday shares of Second Sight Medical Products, Inc. (NASDAQ:EYES) closed at $14.91.

At the Game Developer Conference in San Francisco, Advanced Micro Devices, Inc (NASDAQ:AMD) announced an initiative to deliver the best possible VR experience for developers and users through new AMD technologies and partnerships. The first output of AMD’s initiative is LiquidVR™, a set of innovative technologies focused on enabling exceptional VR content development for AMD hardware, improved comfort in VR applications by facilitating performance, and plug-and-play compatibility with VR headsets. Advanced Micro Devices, Inc. (NASDAQ:AMD) in last trading activity moved down -2.87% to close at $3.05. Company weekly performance is -1.61% while its quarterly performance stands at 14.23%. Advanced Micro Devices, Inc. (NASDAQ:AMD) is -36.46% away from its 52 week high.

The Timken Company (NYSE:TKR) will present at the Bank of America Merrill Lynch Global Industrials & EU Autos Investor Conference on March 17, 2015, at 1:05 p.m. in London (9:05 a.m. Eastern Time). On last trading day The Timken Company (NYSE:TKR) moved down -0.98% to close at $42.55. Its volatility for the week is 1.40% while volatility for the month is 1.58%. TKR’s sales growth for past 5 years was -0.40% and its EPS growth for past 5 years was 34.90%. The Timken Company (NYSE:TKR) monthly performance is 8.63%.

China Yuchai International Ltd. (NYSE:CYD) on Feb 26, reported profit of $39.4 million in its fourth quarter. The Singapore-based company said it had profit of $1.03 per share. China Yuchai International Limited (NYSE:CYD) has 55.14% insider ownership while its institutional ownership stands at 22.10%. In last trading activity company’s stock closed at $19.14.

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) provided an update on its planned clinical trial programs in noninfectious anterior uveitis and Sjögren-Larsson Syndrome, as part of its webcast presentation at the Cowen and Company 35th Annual Healthcare Conference held on Monday, March 2, 2015 at 4:50 p.m. ET. On last trading day Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) moved down -1.98% to close at $10.39. Its volatility for the week is 5.08% while volatility for the month is 7.25%. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) monthly performance is -9.65%.

Stocks on the move: Chevron Corporation (NYSE:CVX), Aldeyra Therapeutics (NASDAQ:ALDX), Workday (NYSE:WDAY), Universal Technical Institute (NYSE:UTI), Star Gas Partners (NYSE:SGU)

On 4 February, Chevron Corporation (NYSE:CVX) announced that its wholly-owned subsidiary Chevron Mauritania Exploration Limited has reached an agreement to acquire a 30 percent non-operated working interest in Blocks C8, C12 and C13 offshore Mauritania from Kosmos Energy. The transaction is subject to the approval of Mauritania’s government. On Tuesday shares of Chevron Corporation (NYSE:CVX) closed at $110.18. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as -0.35%.

On 2 February, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that novel data on its lead product candidate, NS2, has been accepted for two poster presentations at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2015 Annual Meeting, being held May 3-7, 2015 in Denver, Colorado. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) in last trading activity advanced 0.90% to close at $11.25. Company weekly performance is 5.34% while its quarterly performance stands at 58.01%. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) is -16.67% away from its 52 week high.

Workday, Inc. (NYSE: WDAY), plans to announce its fiscal 2015 fourth quarter and full year results after market close on Wednesday, Feb. 25, 2015. On last trading day Workday, Inc. (NYSE:WDAY) advanced 0.06% to close at $86.14. Its volatility for the week is 2.07% while volatility for the month is 3.02%. WDAY’s sales growth for past 5 years was 79.40% and its EPS growth for past 5 years was 15.00%. Workday, Inc. (NYSE:WDAY) monthly performance is 4.29%.

On 5 February, Universal Technical Institute, Inc. (NYSE:UTI) reported revenues for the first quarter ended December 31, 2014 of $95.7 million, a 1.4 percent decrease from $97.0 million for the first quarter of the prior year. Universal Technical Institute, Inc. (NYSE:UTI) has 3.30% insider ownership while its institutional ownership stands at 78.40%. In last trading activity company’s stock closed at $8.27.

on 4 February, Star Gas Partners, L.P. (NYSE:SGU) announced During the fiscal 2015 first quarter, net income declined by $3.7 million to $15.6 million, as an unfavorable change in the fair value of derivative instruments of $13.7 million and the impact of warmer temperatures more than offset the impact of higher home heating oil and propane margins as well as the impact of the Griffith acquisition. On last trading day Star Gas Partners, L.P. (NYSE:SGU) advanced 0.71% to close at $7.10. Its volatility for the week is 3.95% while volatility for the month is 3.16%. SGU’s sales growth for past 5 years was 10.20% and its EPS growth for past 5 years was -15.40%. Star Gas Partners, L.P. (NYSE:SGU) monthly performance is 21.58%.

Mix Sector Stocks News: The Coca-Cola Company (NYSE:KO), Coherus Biosciences (NASDAQ:CHRS), FedEx Corporation (NYSE:FDX), Aldeyra Therapeutics (NASDAQ:ALDX), AdCare Health Systems (NYSEMKT:ADK)

The Coca-Cola Company (NYSE:KO) announced the addition of three brands to its growing roster of beverages that generate annual retail sales of more than $1 billion, bringing to 20 the number of billion-dollar brands in the Company’s portfolio. On Friday shares of The Coca-Cola Company (NYSE:KO) closed at $41.45. Company’s sales growth for last 5 years was 8.00% and EPS growth for next 5 years is recorded as 3.63%.

On Feb 04, Coherus Biosciences, Inc. (NASDAQ:CHRS) announced that it will participate in a fireside chat at the 2015 Leerink Global Healthcare Conference on Wednesday, February 11 at 1:50 pm ET in New York City. Coherus Biosciences, Inc. (NASDAQ:CHRS) in last trading activity advanced 17.51% to close at $28.66. Company weekly performance is 27.72%. Coherus Biosciences, Inc. (NASDAQ:CHRS) is 15.66% away from its 52 week high.

On February 03, FedEx Trade Networks, the freight forwarding and customs brokerage arm of FedEx Corp. (NYSE: FDX), is broadening its services for trade lanes connecting key destinations in Latin America. The trade lanes include the following routes: Germany (Frankfurt) to Mexico (Mexico City and Guadalajara); Germany (Frankfurt) to Brazil (São Paulo and Campinas); Hong Kong to Mexico (Mexico City and Guadalajara) and U.S. (Dallas) to Mexico (Mexico City, Guadalajara and Monterrey). On last trading day FedEx Corporation (NYSE:FDX) fell -0.07% to close at $173.25. Its volatility for the week is 1.50% while volatility for the month is 1.85%. FDX’s sales growth for past 5 years was 5.10% and its EPS growth for past 5 years was 85.20%. FedEx Corporation (NYSE:FDX) monthly performance is 1.29%.

On Jan. 29, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that novel data on the potential of its lead product candidate, NS2, to treat Sjögren-Larsson Syndrome (SLS) has been accepted for a poster presentation at the upcoming 2015 Society for Inherited Metabolic Disorders (SIMD) Annual Meeting, being held March 28-31, 2015 in Salt Lake City, Utah. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) has 0.50% insider ownership while its institutional ownership stands at 81.20%. In last trading activity company’s stock closed at $11.63.

On Feb. 3, AdCare Health Systems Inc. (NYSEMKT:ADK) announced that, as part of its ongoing strategic plan to transition from an owner and operator of healthcare facilities to a healthcare property holding and leasing company, it has signed an agreement with affiliates of Wellington Healthcare Services, an operator of long-term care facilities, to lease two of its skilled nursing facilities in Georgia. On last trading day AdCare Health Systems Inc. (NYSEMKT:ADK) advanced 0.24% to close at $4.14. Its volatility for the week is 2.51% while volatility for the month is 3.47%. ADK’s sales growth for past 5 years was 55.10% and its EPS growth for past 5 years was -25.90%. AdCare Health Systems Inc. (NYSEMKT:ADK) monthly performance is 3.76%.

Notable Moves: Chevron Corporation (NYSE:CVX), Morgan Stanley (NYSE:MS), Aldeyra Therapeutics (NASDAQ:ALDX), Glu Mobile (NASDAQ:GLUU), Deutsche Bank AG (NYSE:DB)

Chevron Corporation (NYSE:CVX), which owns the smaller of the two oil refineries on Oahu, will sell its refinery and retail gas stations in Hawaii by the third quarter of this year, PBN has learned. On Wednesday shares of Chevron Corporation (NYSE:CVX) closed at $108.35. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as -0.89%.

Peak steel arrives in China this year, according to Morgan Stanley (NYSE:MS), which forecast that production and consumption of the alloy will decline after 2015 as the second-largest economy matures. Steel output in the world’s top producer will peak at 806 million metric tons this year, drop to 801 million tons in 2016 and decline further to 795 million tons in 2017, the bank said in a commodities report on Monday. The comments reiterated remarks made by the bank’s analysts in a Dec. 16 note. Morgan Stanley (NYSE:MS) in last trading activity fell -0.77% to close at $34.77. Company weekly performance is 2.96% while its quarterly performance stands at 0.46%. Morgan Stanley (NYSE:MS) is -11.03% away from its 52 week high.

On Feb. 2, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that novel data on its lead product candidate, NS2, has been accepted for two poster presentations at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2015 Annual Meeting, being held May 3-7, 2015 in Denver, Colorado. On last trading day Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) advanced 3.84% to close at $11.09. Its volatility for the week is 7.01% while volatility for the month is 11.81%. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) monthly performance is 45.73%.

Glu Mobile Inc. (NASDAQ:GLUU) reported fourth-quarter net income of $1.38 million or $0.01 per share, compared to a loss of $3.52 million or $0.05 per share, prior year. Adjusted earnings per share was $0.11, for the quarter. On Wednesday shares of Glu Mobile, Inc. (NASDAQ:GLUU) closed at $3.84. Company’s sales growth for last 5 years was 3.30% and EPS growth for next 5 years is recorded as 4.50%.

When investment-banking giant Deutsche Bank AG (NYSE:DB) reports fourth-quarter results Thursday, investors will turn their attention to one particular unit: retail banking. Co-chief executives Anshu Jain and Jürgen Fitschen have been huddling with their finance and strategy chief, Stefan Krause , on a new strategy to overhaul the bank, which they aim to unveil this spring. Among options under debate are selling or floating its Postbank retail subsidiary, according to people familiar with the matter. On last trading day Deutsche Bank AG (NYSE:DB) fell -2.39% to close at $30.63. Its volatility for the week is 1.90% while volatility for the month is 1.99%. DB’s sales growth for past 5 years was -11.90% and its EPS growth for past 5 years was -28.90%. Deutsche Bank AG (NYSE:DB) monthly performance is 6.28%.

Market Alert: BP p.l.c. (NYSE:BP), Aldeyra Therapeutics (NASDAQ:ALDX), M/A-COM Technology Solutions Holdings (NASDAQ:MTSI), Achaogen (NASDAQ:AKAO), Banco Bilbao Vizcaya Argentaria (NYSE:BBVA)

BP Plc (NYSE:BP) said it will slash spending on new projects in 2015 by about 20 percent after recording a quarterly loss in the recent oil-price swoon largely the result of accounting losses because of the diminished value of some of its reserves. Capital expenditure is now expected to be about 20 billion for 2015 substantially lower than earlier guidance of 24 billion to 26 billion and down on last year’s 22.9 billion the London-based company said in a statement. On Tuesday shares of BP p.l.c. (NYSE:BP) closed at $41.10. Company’s sales growth for last 5 years was 1.00% and EPS growth for next 5 years is recorded as 8.30%.

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that novel data on its lead product candidate, NS2, has been accepted for two poster presentations at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2015 Annual Meeting, being held May 3-7, 2015 in Denver, Colorado. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) in last trading activity decreased -7.13% to close at $10.68. Company weekly performance is -2.64% while its quarterly performance stands at 54.78%. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) is -20.89% away from its 52 week high.

M/A-COM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) announced that it has commenced an underwritten public offering of 6,500,000 shares of its common stock, of which 4,500,000 shares are being offered by MACOM and an aggregate of 2,000,000 shares are being offered by John Ocampo, MACOM’s Chairman of the Board and majority stockholder, and his affiliates and certain funds affiliated with Summit Partners, L.P. (collectively, the “Selling Stockholders”). On last trading day M/A-COM Technology Solutions Holdings (NASDAQ:MTSI) decreased -7.43% to close at $29.90. Its volatility for the week is 6.17% while volatility for the month is 5.45%. MTSI’s sales growth for past 5 years was 32.50% and its EPS growth for past 5 years was 15.34%. M/A-COM Technology Solutions Holdings (NASDAQ:MTSI) monthly performance is -5.17%.

Achaogen, Inc. (NASDAQ:AKAO) institutional ownership stands at 92.20%. In last trading activity company’s stock closed at $11.46.

Spanish lender Banco Bilbao Vizcaya Argentaria SA (NYSE:BBVA) has agreed to sell a 4.9 percent stake in China Citic Bank Corp. Ltd. to UBS AG for €1.56 billion ($1.69 billion), it saidon 23 January, marking the second time BBVA has shed part of its Citic stake in less than two years. On last trading day Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) moved up 5.05% to close at $9.15. Its volatility for the week is 2.19% while volatility for the month is 2.03%. BBVA’s sales growth for past 5 years was -5.30% and its EPS growth for past 5 years was -43.40%. Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) monthly performance is -3.99%.

Traders Are Gambling on: Aldeyra Therapeutics (NASDAQ:ALDX), General Motors Company (NYSE:GM), Grupo Financiero Santander Mexico (NYSE:BSMX), Agile Therapeutics (NASDAQ:AGRX), MacroGenics (NASDAQ:MGNX)

Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer and Mr. Stephen Tulipano, Chief Financial Officer of Aldeyra, will participate in the Canaccord Genuity Rare Disease, BioPharma One-on-One Day, being held on Tuesday, February 3, 2015 in New York, NY. On Wednesday shares of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) closed at $11.59.

General Motors Company (NYSE:GM), the largest US automaker and the third-biggest in the world, said it has no intention to further extend the deadline for ignition switch victims’ to file their claims. The company’s independently run ignition switch compensation program has a deadline of January 31 (extended last year by a month) for people to file claims in relation to accidents linked to the 2.6 million cars ignition switch recall initiated last year. General Motors Company (NYSE:GM) in last trading activity moved down -1.74% to close at $32.84. Company weekly performance is -3.10% while its quarterly performance stands at 10.16%. General Motors Company (NYSE:GM) is -12.39% away from its 52 week high.

Grupo Financiero Santander Mexico, S.A.B. de C.V. (NYSE:BSMX) one of the leading financial groups in Mexico, announced that to align its reporting date with its parent company, Banco Santander S.A., it will release its fiscal fourth quarter 2014 financial results before market open on Tuesday, February 3, 2015. On last trading day Grupo Financiero Santander Mexico, S.A.B. de C.V. (NYSE:BSMX) moved down -0.19% to close at $10.79. Its volatility for the week is 2.76% while volatility for the month is 3.40%. Grupo Financiero Santander Mexico, S.A.B. de C.V. (NYSE:BSMX) monthly performance is 6.73%.

On January 21, Agile Therapeutics Inc (NASDAQ:AGRX) announced that it had completed the private placement of approximately 3.4 million shares to raise $20 million. The company signed a definitive stock purchase agreement with institutional accredited investors, both new and existing. Agile Therapeutics, Inc. (NASDAQ:AGRX) has 0.30% insider ownership while its institutional ownership stands at 57.70%. In last trading activity company’s stock closed at $8.02.

MacroGenics, Inc. (NASDAQ:MGNX) announced the closing of the global collaboration and license agreement for MGD011 with Janssen Biotech, Inc. The agreement was announced on December 22, 2014.On last trading day MacroGenics, Inc. (NASDAQ:MGNX) moved down -1.31% to close at $32.31. Its volatility for the week is 5.37% while volatility for the month is 6.35%. MacroGenics, Inc. (NASDAQ:MGNX) monthly performance is -9.14%.

Biotech Stocks New Highs: Aldeyra Therapeutics (NASDAQ:ALDX), Radius Health (NASDAQ:RDUS), Illumina Inc. (NASDAQ:ILMN), Ocular Therapeutix (NASDAQ:OCUL), Codexis (NASDAQ:CDXS)

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer and Mr. Stephen Tulipano, Chief Financial Officer of Aldeyra, will participate in the Canaccord Genuity Rare Disease, BioPharma One-on-One Day, being held on Tuesday, February 3, 2015 in New York, NY. on Facebook On Wednesday shares of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) closed at $11.59.

Radius Health, Inc. (NASDAQ:RDUS) announced the closing of its previously announced public offering of 4,600,000 shares of common stock at a public offering price of $36.75 per share, including 600,000 shares sold pursuant to the full exercise of the underwriters’ option to purchase additional shares of common stock. Radius Health, Inc. (NASDAQ:RDUS) in last trading activity increased 5.10% to close at $46.55. Company weekly performance is 26.15% while its quarterly performance stands at 135.10%. Radius Health, Inc. (NASDAQ:RDUS) is 1.24% away from its 52 week high.

Illumina Inc. (NASDAQ:ILMN) announced Gross margin for fiscal 2014 was 69.7% compared to 64.2% in the prior year; the prior year period included impairment charges of $25.2 million related to the discontinuation of a non-core product line. Excluding the effect of non-cash stock compensation expense, legal contingencies, amortization of acquired intangible assets, and impairments, non-GAAP gross margin was 71.7% for fiscal 2014 compared to 70.1% in the prior year. On last trading day Illumina Inc. (NASDAQ:ILMN) fell -2.65% to close at $197.86. Its volatility for the week is 4.64% while volatility for the month is 4.19%. ILMN’s sales growth for past 5 years was 19.90% and its EPS growth for past 5 years was 24.60%. Illumina Inc. (NASDAQ:ILMN) monthly performance is 5.13%.

Ocular Therapeutix™, Inc. (NASDAQ:OCUL), announced on 21 January enrollment of the first patient in a Phase 2 clinical trial to evaluate the safety and efficacy of Sustained Release Dexamethasone (OTX-DP), an ophthalmic corticosteroid for the treatment of inflammatory dry eye disease. Ocular Therapeutix’s dexamethasone is being developed for administration as a one-time, bioresorbable intracanalicular plug for drug release to the ocular surface for up 30 days. Ocular Therapeutix, Inc. (NASDAQ:OCUL) has 3.30% insider ownership while its institutional ownership stands at 70.10%. In last trading activity company’s stock closed at $28.83.

Zacks cut shares of Codexis (NASDAQ:CDXS) to a neutral rating in a research report sent to investors on Friday morning. The firm currently has $3.10 price target on the stock.On last trading day Codexis, Inc. (NASDAQ:CDXS) increased 3.10% to close at $3.33. Its volatility for the week is 6.74% while volatility for the month is 7.08%. CDXS’s sales growth for past 5 years was -8.80% and its EPS growth for past 5 years was 43.60%. Codexis, Inc. (NASDAQ:CDXS) monthly performance is 30.59%.